Long-term CPAP compliance in women with obstructive sleep apnoea

F. Campos-Rodríguez, M.A. Martínez-García, N. Reyes-Núñez, C.V. Almeida-González, P. Catalán-Serra, J.M. Montserrat (Sevilla, Valencia, Barcelona, Spain)

Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Session: CPAP: beneficial effects on different aspects of health
Session type: Poster Discussion
Number: 434
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Campos-Rodríguez, M.A. Martínez-García, N. Reyes-Núñez, C.V. Almeida-González, P. Catalán-Serra, J.M. Montserrat (Sevilla, Valencia, Barcelona, Spain). Long-term CPAP compliance in women with obstructive sleep apnoea. Eur Respir J 2012; 40: Suppl. 56, 434

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Determinants of CPAP compliance in bariatric patients with obstructive sleep apnoea
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017

Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002

Role of CPAP treatment in elderly with moderate obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004

Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009

Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002

Efficacy of a FOT-based auto-CPAP device for the treatment of obstructive sleep apnea
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018




Long-term continuous positive airway pressure compliance in females with obstructive sleep apnoea
Source: Eur Respir J 2013; 42: 1255-1262
Year: 2013



Improving adherence to treatment in patients with obstructive sleep apnoea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


Effects of nCPAP treatment on quality of life of patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 410s
Year: 2006

Short- and long-term prevalence of complex sleep apnoea in patients treated for obstructive sleep apnoea
Source: Annual Congress 2009 - Complex sleep apnoea and adaptive servo ventilation
Year: 2009


Nasal resistance and CPAP compliance in a large series of obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 408s
Year: 2006

AutoCPAP in obstructive sleep apnea (OSA) patients with poor compliance to standard CPAP titration
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006

The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 103s
Year: 2002

Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012


Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019


Objective compliance with oral appliance therapy versus CPAP in moderate obstructive sleep apnea
Source: International Congress 2017 – CPAP therapy
Year: 2017


Telecoaching to improve physical activity in patients with obstructive sleep apnea treated with CPAP
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020